Intravascular Imaging-guided Versus Angiography-guided Percutaneous Coronary Intervention: a Systematic Review and Bayesian Network Meta-analysis of Randomized Controlled Trials

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2024 Sep 11

PMID 39261775

Authors

Ahmed Mazen Amin

Yehya Khlidj

Mohamed Abuelazm

Ahmed Sayed

Ubaid Khan

Mariam Mahmoud Elewidi

Mohammad Tanashat

Hesham Elharti

Mohamed Hatem Ellabban

Abdullah K Alassiri

Mohamad Alsaed

Basel Abdelazeem

Akram Kawsara

Affiliations

Soon will be listed here.

Abstract

Background: Percutaneous coronary intervention (PCI) has become one of the most commonly performed interventional life-saving procedures worldwide. Intravascular Imaging (intravascular ultrasound (IVUS) and optical coherence tomography (OCT)) have initially evolved to guide PCI compared with angiography. However, this technology is not universally employed in all PCI procedures, and there is ongoing controversy regarding its additional benefits to patient outcomes. We aim to estimate the efficacy and safety of imaging modalities during PCI, allowing pre-, per, and post-intervention assessment of coronary vascularization.

Methods: A systematic review and Bayesian network meta-analysis of randomized controlled trials (RCTs), which were retrieved from PubMed, WOS, SCOPUS, EMBASE, and CENTRAL through September 2023. We used R, version 4.2.0. Effect sizes will be presented as odds ratios with accompanying 95% credible intervals.

Prospero Id: CRD42024507821.

Results: Our study, encompassing 36 RCTs with a total of 17,572 patients, revelead that compared to conventional angiography, IVUS significantly reduced the risk of major adverse cardiovascular events (MACE) (OR: 0.71 [95% CrI: 0.56 to 0.87]) but not OCT (OR: 0.91 [95% CrI: 0.62 to 1.39]), IVUS and OCT significantly reduced the risk of cardiac death (OR: 0.50 [95% CrI: 0.33 to 0.76]) and (OR: 0.55 [95% CrI: 0.31 to 0.98]), respectively, IVUS significantly reduced the risk of target vessel-related revascularization (OR: 0.60 [95% CrI: 0.48 to 0.75]) but not OCT (OR: 0.86 [95% CrI: 0.60 to 1.19]), IVUS and OCT significantly reduced the risk of stent thrombosis (OR: 0.50 [95% CrI: 0.28 to 0.92]) and (OR: 0.48 [95% CrI: 0.22 to 0.98]), respectively, IVUS significantly reduced the risk of re-stenosis (OR: 0.65 [95% CrI: 0.46 to 0.88]) but not OCT (OR: 0.55 [95% CrI: 0.15 to 1.99]), neither IVUS (OR: 0.97 [95% CrI: 0.71 to 1.38]) nor OCT (OR: 0.75 [95% CrI: 0.49 to 1.22]) were associated with statistically significant reductions in all-cause mortality, neither IVUS (OR: 0.70 [95% CrI: 0.45 to 1.32]) nor OCT (OR: 0.81 [95% CrI: 0.47 to 1.59]) were associated with statistically significant reductions in target vessel failure, neither IVUS (OR: 0.88 [95% CrI: 0.43 to 2.44]) nor OCT (OR: 0.81 [95% CrI: 0.37 to 2.04]) were associated with statistically significant reductions in target lesion failure, and neither IVUS (OR: 0.82 [95% CrI: 0.60 to 1.06]) nor OCT (OR: 0.84 [95% CrI: 0.59 to 1.19]) were associated with statistically significant reductions in myocardial infarction.

Conclusion: Intravascular imaging-guided, including IVUS and OCT, improved the postinterventional outcomes of PCI, notably suggesting their advantage over traditional angiography with no significant difference between IVUS and OCT.

References

Chieffo A, Latib A, Caussin C, Presbitero P, Galli S, Menozzi A . A prospective, randomized trial of intravascular-ultrasound guided compared to angiography guided stent implantation in complex coronary lesions: the AVIO trial. Am Heart J. 2012; 165(1):65-72. DOI: 10.1016/j.ahj.2012.09.017. View

Gaster A, Slothuus U, Larsen J, Thayssen P, Haghfelt T . Cost-effectiveness analysis of intravascular ultrasound guided percutaneous coronary intervention versus conventional percutaneous coronary intervention. Scand Cardiovasc J. 2001; 35(2):80-5. DOI: 10.1080/140174301750164673. View

Ali Z, Galougahi K, Maehara A, Shlofmitz R, Fabbiocchi F, Guagliumi G . Outcomes of optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation: one-year results from the ILUMIEN III: OPTIMIZE PCI trial. EuroIntervention. 2020; 16(13):1085-1091. PMC: 9724851. DOI: 10.4244/EIJ-D-20-00498. View

Sakakura K, Yamamoto K, Taniguchi Y, Tsurumaki Y, Momomura S, Fujita H . Intravascular ultrasound enhances the safety of rotational atherectomy. Cardiovasc Revasc Med. 2017; 19(3 Pt A):286-291. DOI: 10.1016/j.carrev.2017.09.012. View

Meneveau N, Souteyrand G, Motreff P, Caussin C, Amabile N, Ohlmann P . Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize.... Circulation. 2016; 134(13):906-17. DOI: 10.1161/CIRCULATIONAHA.116.024393. View

Gaster A, Slothuus Skjoldborg U, Larsen J, Korsholm L, von Birgelen C, Jensen S . Continued improvement of clinical outcome and cost effectiveness following intravascular ultrasound guided PCI: insights from a prospective, randomised study. Heart. 2003; 89(9):1043-9. PMC: 1767812. DOI: 10.1136/heart.89.9.1043. View

Gori T, Polimeni A, Indolfi C, Raber L, Adriaenssens T, Munzel T . Predictors of stent thrombosis and their implications for clinical practice. Nat Rev Cardiol. 2018; 16(4):243-256. DOI: 10.1038/s41569-018-0118-5. View

Zhang J, Gao X, Kan J, Ge Z, Han L, Lu S . Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial. J Am Coll Cardiol. 2018; 72(24):3126-3137. DOI: 10.1016/j.jacc.2018.09.013. View

Wang H, Dong P, Li Z, Wang H, Wang K, Liu X . Application of Intravascular Ultrasound in the Emergency Diagnosis and Treatment of Patients with ST-Segment Elevation Myocardial Infarction. Echocardiography. 2014; 32(6):1003-8. DOI: 10.1111/echo.12794. View

10.

Lawton J, Tamis-Holland J, Bangalore S, Bates E, Beckie T, Bischoff J . 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021; 145(3):e4-e17. DOI: 10.1161/CIR.0000000000001039. View

11.

Choi K, Song Y, Lee J, Lee S, Park T, Yang J . Impact of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention on Long-Term Clinical Outcomes in Patients Undergoing Complex Procedures. JACC Cardiovasc Interv. 2019; 12(7):607-620. DOI: 10.1016/j.jcin.2019.01.227. View

12.

Tian N, Gami S, Ye F, Zhang J, Liu Z, Lin S . Angiographic and clinical comparisons of intravascular ultrasound- versus angiography-guided drug-eluting stent implantation for patients with chronic total occlusion lesions: two-year results from a randomised AIR-CTO study. EuroIntervention. 2015; 10(12):1409-17. DOI: 10.4244/EIJV10I12A245. View

13.

Olinic D, Spinu M, Homorodean C, Ober M, Olinic M . Real-Life Benefit of OCT Imaging for Optimizing PCI Indications, Strategy, and Results. J Clin Med. 2019; 8(4). PMC: 6518208. DOI: 10.3390/jcm8040437. View

14.

Lee S, Kang D, Hong S, Ahn J, Ahn C, Park D . Optical Coherence Tomography for Coronary Bioresorbable Vascular Scaffold Implantation: A Randomized Controlled Trial. Circ Cardiovasc Interv. 2020; 13(1):e008383. DOI: 10.1161/CIRCINTERVENTIONS.119.008383. View

15.

Antonsen L, Thayssen P, Maehara A, Hansen H, Junker A, Veien K . Optical Coherence Tomography Guided Percutaneous Coronary Intervention With Nobori Stent Implantation in Patients With Non-ST-Segment-Elevation Myocardial Infarction (OCTACS) Trial: Difference in Strut Coverage and Dynamic Malapposition Patterns at.... Circ Cardiovasc Interv. 2015; 8(8):e002446. DOI: 10.1161/CIRCINTERVENTIONS.114.002446. View

16.

Muramatsu T, Ozaki Y, Nanasato M, Ishikawa M, Nagasaka R, Ohota M . Comparison Between Optical Frequency Domain Imaging and Intravascular Ultrasound for Percutaneous Coronary Intervention Guidance in Biolimus A9-Eluting Stent Implantation: A Randomized MISTIC-1 Non-Inferiority Trial. Circ Cardiovasc Interv. 2020; 13(11):e009314. PMC: 7665240. DOI: 10.1161/CIRCINTERVENTIONS.120.009314. View

17.

Bergmark B, Osborn E, Ali Z, Gupta A, Kolli K, Prillinger J . Association Between Intracoronary Imaging During PCI and Clinical Outcomes in a Real-World US Medicare Population. J Soc Cardiovasc Angiogr Interv. 2024; 2(2):100556. PMC: 11307420. DOI: 10.1016/j.jscai.2022.100556. View

18.

Kim Y, Bae S, Johnson T, Son N, Sim D, Hong Y . Role of Intravascular Ultrasound-Guided Percutaneous Coronary Intervention in Optimizing Outcomes in Acute Myocardial Infarction. J Am Heart Assoc. 2022; 11(5):e023481. PMC: 9075077. DOI: 10.1161/JAHA.121.023481. View

19.

Tavakol M, Ashraf S, Brener S . Risks and complications of coronary angiography: a comprehensive review. Glob J Health Sci. 2012; 4(1):65-93. PMC: 4777042. DOI: 10.5539/gjhs.v4n1p65. View

20.

Mariani Jr J, Guedes C, Soares P, Zalc S, Campos C, Lopes A . Intravascular ultrasound guidance to minimize the use of iodine contrast in percutaneous coronary intervention: the MOZART (Minimizing cOntrast utiliZation With IVUS Guidance in coRonary angioplasTy) randomized controlled trial. JACC Cardiovasc Interv. 2014; 7(11):1287-93. PMC: 4637944. DOI: 10.1016/j.jcin.2014.05.024. View